These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 7744226)

  • 1. The fourth musketeer--from Alexandre Dumas to Claude Bernard.
    Reaven GM
    Diabetologia; 1995 Jan; 38(1):3-13. PubMed ID: 7744226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.
    DeFronzo RA
    Diabetes; 1988 Jun; 37(6):667-87. PubMed ID: 3289989
    [No Abstract]   [Full Text] [Related]  

  • 3. Adipose tissue glucose transporters in NIDDM. Decreased levels of muscle/fat isoform.
    Sinha MK; Raineri-Maldonado C; Buchanan C; Pories WJ; Carter-Su C; Pilch PF; Caro JF
    Diabetes; 1991 Apr; 40(4):472-7. PubMed ID: 2010047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of abnormal muscle and liver glucose metabolism to postprandial hyperglycemia in NIDDM.
    Mitrakou A; Kelley D; Veneman T; Jenssen T; Pangburn T; Reilly J; Gerich J
    Diabetes; 1990 Nov; 39(11):1381-90. PubMed ID: 2121568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: the role of skeletal muscle glucose uptake and hepatic glucose production in the development of hyperglycaemia. A critical comment.
    Beck-Nielsen H; Hother-Nielsen O; Vaag A; Alford F
    Diabetologia; 1994 Feb; 37(2):217-21. PubMed ID: 8163059
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of pioglitazone on glucose and lipid metabolism in Wistar fatty rats.
    Sugiyama Y; Taketomi S; Shimura Y; Ikeda H; Fujita T
    Arzneimittelforschung; 1990 Mar; 40(3):263-7. PubMed ID: 2189419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin action kinetics in adipocytes from obese and noninsulin-dependent diabetes mellitus subjects: identification of multiple cellular defects in glucose transport.
    Ciaraldi TP; Molina JM; Olefsky JM
    J Clin Endocrinol Metab; 1991 Apr; 72(4):876-82. PubMed ID: 2005215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM.
    Vaag A; Alford F; Henriksen FL; Christopher M; Beck-Nielsen H
    Diabetologia; 1995 Mar; 38(3):326-36. PubMed ID: 7758880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased activation of skeletal muscle glycogen synthase by mixed-meal ingestion in NIDDM.
    Wright KS; Beck-Nielsen H; Kolterman OG; Mandarino LJ
    Diabetes; 1988 Apr; 37(4):436-40. PubMed ID: 2837418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonobese, insulin-deficient Ins2Akita mice develop type 2 diabetes phenotypes including insulin resistance and cardiac remodeling.
    Hong EG; Jung DY; Ko HJ; Zhang Z; Ma Z; Jun JY; Kim JH; Sumner AD; Vary TC; Gardner TW; Bronson SK; Kim JK
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1687-96. PubMed ID: 17911348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-receptor kinase activity of adipose tissue from morbidly obese humans with and without NIDDM.
    Sinha MK; Pories WJ; Flickinger EG; Meelheim D; Caro JF
    Diabetes; 1987 May; 36(5):620-5. PubMed ID: 3032715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effect of insulin on glucose transport and insulin binding in cultured adipocytes from normal and obese humans with and without non-insulin-dependent diabetes.
    Sinha MK; Taylor LG; Pories WJ; Flickinger EG; Meelheim D; Atkinson S; Sehgal NS; Caro JF
    J Clin Invest; 1987 Oct; 80(4):1073-81. PubMed ID: 3308958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperglycemia normalizes insulin-stimulated skeletal muscle glucose oxidation and storage in noninsulin-dependent diabetes mellitus.
    Kelley DE; Mandarino LJ
    J Clin Invest; 1990 Dec; 86(6):1999-2007. PubMed ID: 2123890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose transporter proteins and insulin sensitivity in humans.
    Garvey WT
    Braz J Med Biol Res; 1994 Apr; 27(4):933-9. PubMed ID: 8087095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the pathophysiology of late onset non-insulin dependent diabetes mellitus. Current controversies and new insights.
    Vaag A
    Dan Med Bull; 1999 Jun; 46(3):197-234. PubMed ID: 10421979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of sulfonylureas on adipocyte and skeletal muscle insulin action in patients with non-insulin-dependent diabetes mellitus.
    Pedersen O; Hother-Nielsen O; Bak J; Hjollund E; Beck-Nielsen H
    Am J Med; 1991 Jun; 90(6A):22S-28S. PubMed ID: 1908182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Decreased first-phase secretion of insulin may play a role in the development of insulin resistance].
    Wittmann I; Soltész G; Jermendy G; Nagy J
    Orv Hetil; 2004 Nov; 145(45):2267-72. PubMed ID: 15573890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular mechanisms of insulin resistance in non-insulin-dependent (type II) diabetes.
    Olefsky JM; Garvey WT; Henry RR; Brillon D; Matthaei S; Freidenberg GR
    Am J Med; 1988 Nov; 85(5A):86-105. PubMed ID: 3057897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial dysfunction and diabetes: roles of hyperglycemia, impaired insulin signaling and obesity.
    Bakker W; Eringa EC; Sipkema P; van Hinsbergh VW
    Cell Tissue Res; 2009 Jan; 335(1):165-89. PubMed ID: 18941783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of insulin resistance in New Zealand obese mice.
    Veroni MC; Proietto J; Larkins RG
    Diabetes; 1991 Nov; 40(11):1480-7. PubMed ID: 1936607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.